论文部分内容阅读
许多西方国家及中国、日本等均报道,肥厚型心肌病患病率约为1/500,是一种全球性疾病。中国8080例人群超声心动图调查结果显示,全国约有肥厚型心肌病患者100万人。以往文献报道,多数患者来自大的教学医院,不能代表社区肥厚型心肌病患者的实际。调查显示,多数肥厚型心肌病患者能够过正常或接近正常人的生活,有与常人相近的寿命。即使高危患者,绝大多数经过手术及安装体内除颤起搏装置(ICD),亦能解除危及他们生命的左室流出道梗阻及恶性心律失常,获得与正常人相近的生活质量与寿命。
Many western countries and China, Japan and other reports have reported that the prevalence of hypertrophic cardiomyopathy is about 1/500, is a global disease. China 8080 cases of echocardiography survey showed that about 1 million people with hypertrophic cardiomyopathy in the country. According to previous reports, most patients come from large teaching hospitals and can not represent the actual situation of patients with hypertrophic cardiomyopathy in the community. Survey shows that most patients with hypertrophic cardiomyopathy can be normal or close to normal life, and life similar to ordinary people. Even high-risk patients, most of whom undergo surgery and install defibrillation and pacemaker devices (ICDs), can also relieve the obstruction of their left ventricular outflow tract obstruction and malignant arrhythmia and achieve similar quality of life and life expectancy as their normal counterparts.